Octane, a leading organization supporting technology growth in Southern California, has announced the Octane Cardiovascular Tech Forum 2025 will take place September 11-12, 2025, at VEA Newport Beach, A Marriott Resort & Spa. The event represents a significant gathering for the cardiovascular technology sector, bringing together entrepreneurs, investors, physicians, and industry leaders to showcase the latest advances in interventional cardiology, digital health, imaging, and medical devices.
The forum's program includes innovation panels, physician and entrepreneur workshops, investor-focused presentations, and networking sessions designed to foster collaboration and accelerate the development of cardiovascular technologies. Dr. John B. Simpson, a pioneering interventional cardiologist and inventor of the over-the-wire balloon angioplasty catheter, will serve as the keynote speaker, bringing decades of medical innovation experience to the event.
A distinguished committee featuring leaders from Edwards Lifesciences, Cathworks, Knobbe Martens, UC Irvine, Hoag Hospital, and Nidus Biomedical will guide the forum's agenda and content development. This diverse representation from industry, academia, and clinical practice ensures the event will address the most pressing challenges and opportunities in cardiovascular care.
According to Octane CEO Bill Carpou, the forum aims to accelerate solutions that can redefine patient outcomes and strengthen the healthcare ecosystem. The event serves as a cornerstone of Octane's Innovation Event Series, which focuses on connecting people, resources, and capital to drive technological advancement in Southern California's growing tech and medtech industries.
The Cardiovascular Tech Forum 2025 represents an important opportunity for stakeholders across the cardiovascular technology landscape to collaborate, share knowledge, and identify promising innovations that could transform patient care. By bringing together diverse perspectives from clinical practice, research, investment, and industry, the event aims to address critical challenges in cardiovascular medicine while fostering the development of next-generation technologies.
